Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Transplantation | 5 | 2020 | 352 | 1.530 |
Why?
|
| Asthma | 6 | 2021 | 921 | 0.900 |
Why?
|
| Energy Metabolism | 4 | 2016 | 800 | 0.840 |
Why?
|
| Arginine | 4 | 2016 | 337 | 0.790 |
Why?
|
| Fungi | 2 | 2021 | 72 | 0.760 |
Why?
|
| Citrulline | 3 | 2015 | 123 | 0.710 |
Why?
|
| Transplant Recipients | 2 | 2021 | 228 | 0.700 |
Why?
|
| Burnout, Professional | 1 | 2023 | 134 | 0.670 |
Why?
|
| Nitric Oxide | 4 | 2015 | 465 | 0.650 |
Why?
|
| Allergens | 2 | 2021 | 344 | 0.640 |
Why?
|
| Tacrolimus | 1 | 2020 | 102 | 0.620 |
Why?
|
| Fibrinolysis | 1 | 2019 | 44 | 0.590 |
Why?
|
| Pleura | 1 | 2019 | 27 | 0.590 |
Why?
|
| Surgeons | 1 | 2023 | 288 | 0.570 |
Why?
|
| Pleural Effusion | 1 | 2019 | 104 | 0.560 |
Why?
|
| Immunity, Innate | 1 | 2021 | 409 | 0.550 |
Why?
|
| Catheterization | 1 | 2019 | 223 | 0.540 |
Why?
|
| Shock, Septic | 2 | 2009 | 148 | 0.540 |
Why?
|
| Drainage | 1 | 2019 | 247 | 0.530 |
Why?
|
| Drug Monitoring | 1 | 2020 | 288 | 0.520 |
Why?
|
| Bone Density | 1 | 2020 | 366 | 0.520 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 643 | 0.510 |
Why?
|
| Sepsis | 2 | 2013 | 494 | 0.510 |
Why?
|
| Graft Rejection | 1 | 2020 | 558 | 0.490 |
Why?
|
| Nutritional Requirements | 1 | 2015 | 160 | 0.420 |
Why?
|
| Weight Gain | 1 | 2016 | 382 | 0.410 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 736 | 0.390 |
Why?
|
| Severity of Illness Index | 6 | 2021 | 3032 | 0.390 |
Why?
|
| Enterocytes | 1 | 2013 | 68 | 0.380 |
Why?
|
| Glutamine | 1 | 2013 | 201 | 0.350 |
Why?
|
| Pyruvic Acid | 1 | 2011 | 35 | 0.350 |
Why?
|
| Rest | 1 | 2011 | 64 | 0.330 |
Why?
|
| Tuberculosis | 1 | 2016 | 554 | 0.320 |
Why?
|
| Models, Biological | 1 | 2015 | 1384 | 0.310 |
Why?
|
| Glucose | 2 | 2011 | 853 | 0.310 |
Why?
|
| Pectoralis Muscles | 2 | 2020 | 6 | 0.290 |
Why?
|
| Proteins | 2 | 2011 | 1008 | 0.280 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 273 | 0.270 |
Why?
|
| Retrospective Studies | 10 | 2021 | 17517 | 0.260 |
Why?
|
| Carbon Isotopes | 3 | 2015 | 228 | 0.260 |
Why?
|
| Middle Aged | 12 | 2020 | 28369 | 0.250 |
Why?
|
| Female | 20 | 2021 | 70344 | 0.240 |
Why?
|
| Male | 17 | 2021 | 64424 | 0.230 |
Why?
|
| Leucine | 3 | 2013 | 258 | 0.230 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 286 | 0.230 |
Why?
|
| Humans | 24 | 2023 | 130383 | 0.220 |
Why?
|
| Respiration, Artificial | 1 | 2008 | 505 | 0.220 |
Why?
|
| Th2 Cells | 3 | 2021 | 188 | 0.220 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2018 | 134 | 0.210 |
Why?
|
| Nitrogen Isotopes | 2 | 2015 | 45 | 0.210 |
Why?
|
| Lung | 3 | 2021 | 1535 | 0.200 |
Why?
|
| Depersonalization | 1 | 2023 | 10 | 0.200 |
Why?
|
| Adult | 12 | 2020 | 31130 | 0.180 |
Why?
|
| Antigens, Fungal | 1 | 2021 | 32 | 0.170 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2020 | 22 | 0.160 |
Why?
|
| Warfarin | 1 | 2021 | 123 | 0.150 |
Why?
|
| Absorptiometry, Photon | 1 | 2020 | 197 | 0.150 |
Why?
|
| Lymphocytes | 1 | 2021 | 348 | 0.150 |
Why?
|
| Administration, Oral | 1 | 2021 | 708 | 0.140 |
Why?
|
| Receptors, Interleukin-13 | 1 | 2018 | 4 | 0.140 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2018 | 11 | 0.140 |
Why?
|
| Acute Disease | 1 | 2020 | 1147 | 0.130 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 178 | 0.130 |
Why?
|
| Pulmonary Atelectasis | 1 | 2017 | 15 | 0.130 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2017 | 42 | 0.120 |
Why?
|
| Aged | 5 | 2020 | 20860 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2021 | 602 | 0.120 |
Why?
|
| Demography | 1 | 2016 | 236 | 0.120 |
Why?
|
| Indicator Dilution Techniques | 1 | 2015 | 24 | 0.110 |
Why?
|
| Exhalation | 1 | 2015 | 16 | 0.110 |
Why?
|
| Jamaica | 1 | 2015 | 29 | 0.110 |
Why?
|
| Isotopes | 1 | 2015 | 24 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 383 | 0.110 |
Why?
|
| Ornithine | 1 | 2015 | 31 | 0.110 |
Why?
|
| Deuterium | 1 | 2015 | 95 | 0.110 |
Why?
|
| Spectrum Analysis | 1 | 2015 | 58 | 0.110 |
Why?
|
| Prognosis | 3 | 2019 | 4859 | 0.110 |
Why?
|
| Meals | 1 | 2015 | 59 | 0.110 |
Why?
|
| Phenylalanine | 1 | 2015 | 131 | 0.110 |
Why?
|
| India | 1 | 2015 | 245 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3795 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2018 | 383 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2011 | 3362 | 0.100 |
Why?
|
| Splanchnic Circulation | 1 | 2013 | 49 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 4027 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2017 | 396 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 5163 | 0.090 |
Why?
|
| Body Composition | 1 | 2015 | 544 | 0.090 |
Why?
|
| Radioactive Tracers | 1 | 2011 | 20 | 0.090 |
Why?
|
| Glycolysis | 1 | 2011 | 176 | 0.080 |
Why?
|
| Mitochondria | 1 | 2016 | 777 | 0.080 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2010 | 61 | 0.080 |
Why?
|
| Lasers | 1 | 2010 | 111 | 0.080 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 535 | 0.080 |
Why?
|
| Breath Tests | 1 | 2010 | 182 | 0.070 |
Why?
|
| Biomarkers | 3 | 2018 | 3383 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2011 | 828 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2010 | 314 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 761 | 0.070 |
Why?
|
| Receptors, GABA | 1 | 2008 | 16 | 0.070 |
Why?
|
| Quality of Life | 1 | 2017 | 2082 | 0.070 |
Why?
|
| Kinetics | 1 | 2009 | 1088 | 0.070 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 238 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3401 | 0.060 |
Why?
|
| Texas | 1 | 2015 | 3643 | 0.060 |
Why?
|
| Status Epilepticus | 1 | 2008 | 158 | 0.060 |
Why?
|
| Liver | 1 | 2013 | 1788 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2018 | 4673 | 0.060 |
Why?
|
| Homeostasis | 1 | 2009 | 714 | 0.050 |
Why?
|
| Neurons | 2 | 2010 | 2013 | 0.050 |
Why?
|
| Algorithms | 1 | 2010 | 1660 | 0.050 |
Why?
|
| Pregnancy | 2 | 2010 | 7418 | 0.040 |
Why?
|
| United States | 1 | 2016 | 11859 | 0.040 |
Why?
|
| Inflammation | 2 | 2018 | 1483 | 0.040 |
Why?
|
| Inhibitory Postsynaptic Potentials | 2 | 2010 | 29 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 2 | 2010 | 272 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 6786 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 425 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2016 | 34 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 29 | 0.030 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2016 | 34 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 90 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2016 | 98 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 356 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 215 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 125 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1210 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2017 | 500 | 0.030 |
Why?
|
| Adolescent | 2 | 2010 | 20723 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1487 | 0.020 |
Why?
|
| Rats | 2 | 2010 | 3374 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2016 | 525 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 1585 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2008 | 12841 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 2110 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 1573 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2295 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2193 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 2829 | 0.020 |
Why?
|
| Phosphinic Acids | 1 | 2010 | 1 | 0.020 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2010 | 7 | 0.020 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2010 | 15 | 0.020 |
Why?
|
| Pharynx | 1 | 2010 | 65 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 2688 | 0.020 |
Why?
|
| Bicuculline | 1 | 2010 | 17 | 0.020 |
Why?
|
| Benzylamines | 1 | 2010 | 22 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2010 | 60 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2010 | 83 | 0.020 |
Why?
|
| Valine | 1 | 2010 | 110 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 290 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 677 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2062 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2010 | 173 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 403 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 5047 | 0.020 |
Why?
|
| Pilocarpine | 1 | 2008 | 10 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3673 | 0.020 |
Why?
|
| Diazepam | 1 | 2008 | 20 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 4471 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2008 | 58 | 0.020 |
Why?
|
| Lithium | 1 | 2008 | 66 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1929 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 2008 | 105 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 447 | 0.020 |
Why?
|
| Zinc | 1 | 2008 | 128 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 1339 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 809 | 0.020 |
Why?
|
| Animals | 3 | 2016 | 33817 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 1105 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2008 | 362 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2900 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2010 | 1675 | 0.010 |
Why?
|
| Hippocampus | 1 | 2008 | 793 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10948 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 18214 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 2381 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 4667 | 0.010 |
Why?
|